A Mathematical Model of Breast Cancer Treatment with CMF and Doxorubicin

Bulletin of Mathematical Biology

Volumn 73, Issue 3, 2011, Pages 585-608

  Roe Dale, Rachel ^a   Isaacson, David ^b   Kupferschmid, Michael ^c  

^a SKIDMORE COLLEGE   (United States)

^b Rensselaer Polytechnic Institute   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Breast cancer; Cell cycle; Drug order; Drug resistance; Mathematical model

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; FEMALE; HUMAN;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MODELS, BIOLOGICAL;

EID: 79952575410     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-010-9549-9     Document Type: Article

References (19)

1. Bast, R. C. et al. (Eds.) (2005). Cancer medicine. New York: Decker.
2. Bonadonna, G., Zambetti, M., & Valagussa, P. (1991). Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. J. Am. Med. Assoc., 7, 542-547.
3. Ecker, J., & Kupferschmid, M. (2004). Introduction to operations research. Melbourne: Krieger.
4. Edelstein-Keshet, L. (1988). Mathematical models in biology. New York: McGraw-Hill.
5. Chaudhary, P., & Roninson, I. (1993). Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst., 85, 632-639.
6. Goldie, J., & Coldman, A. (1983). Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat. Rep., 67, 923-931.
7. Gringauz, A. (1997). Introduction to medicinal chemistry: how drugs act and why. New York-Weinheim: Wiley-VCH.
8. Michelson, S., & Slate, D. (1992). A mathematical model of the p-glycoprotein pump as a mediator of multidrug resistance. Bull. Math. Biol., 54, 1023-1038.
9. Motwani, M., Delohery, T., & Schwartz, G. (1999). Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin. Cancer Res., 5, 1876-1883.
10. Motwani, M. et al. (2003). Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. Mol. Cancer Ther., 2, 549-555.
11. Norton, L., & Simon, R. (1977). Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat. Rep., 61, 1307-1317.
12. Norton, L., & Simon, R. (1986). The Norton-Simon hypothesis revisited. Cancer Treat. Rep., 70, 163-169.
13. Panetta, J., & Adam, J. (1995). A mathematical model of cycle-specific chemotherapy. Math. Comput. Model., 22, 67-82.
14. Silvestrini, R. et al. (2000). Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer. Int. J. Cancer, 87, 405-411.
15. Takahashi, M. (1966). Theoretical basis for cell cycle analysis I: labelled mitosis wave method. J. Theor. Biol., 13, 202-211.
16. Takahashi, M. (1968). Theoretical basis for cell cycle analysis II: further studies on labelled mitosis wave method. J. Theor. Biol., 18, 195-209.
17. Tannock, I., & Hill, R. (1998). The basic science of oncology (3rd ed.). New York: McGraw-Hill.
18. Weldon, T. E. (1988). Mathematical models in cancer research. Bristol: Hilger.
19. Westman, J., Fabijona, B., Kern, D., & Hanson, F. (2001). Cancer treatment using multiple chemotherapeutic agents subject to drug resistance. In Proceedings of the 15th international symposium on mathematical theory of networks and systems.